regulatory
confidence high
sentiment positive
materiality 0.65
FDA clears Tandem Mobi insulin pump for pediatric use ages 2+
TANDEM DIABETES CARE INC
- FDA cleared Tandem Mobi insulin pump for expanded pediatric indication in individuals two years and older.
- Clearance was granted via 510(k) application on March 21, 2024.
- Indication expansion broadens Tandem's addressable patient population beyond prior adult-only use.